🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Fluzone® (intramuscular)

Found 163 matching trials

Trial of Tolerability, Safety and Immunogenicity of the Flu-M Vaccine in Children Between 6 Months and 9 Years Old

PHASE3

Comparative trial of tolerability, reactogenicity, safety and immunogenicit...

Status

Completed

Location

LLC "Energiya zdorov'ya"

Start Date

2021-02-16

Trial ID

NCT05470582

Treatments Being Tested

Flu-M, Inactivated split influenza vaccine 0.5 mL Vaxigrip, Inactivated split influenza vaccine 0.5 mL Flu-M, Inactivated split influenza vaccine 0.25 mL Vaxigrip, Inactivated split influenza vaccine 0.25 mL

Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children

PHASE2

Primary Objective: To evaluate for each influenza strain the non-inferiori...

Status

Completed

Location

Multiple Locations

Start Date

2006-10

Trial ID

NCT00391391

Treatments Being Tested

Split, Inactivated, Trivalent Influenza Vaccine Split, Inactivated, Trivalent Influenza Vaccine Split, Inactivated, Trivalent Influenza Vaccine ( Fluzone® 2006/2007 Formulation)Split, Inactivated, Trivalent Influenza Vaccine ( Fluzone® 2006/2007 Formulation)

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Quadrivalent Influenza Virus Vaccine

PHASE4

The aim of this study is to evaluate the safety and immunogenicity of Fluzo...

Status

Completed

Location

Multiple Locations

Start Date

2013-09

Trial ID

NCT01946425

Treatments Being Tested

Fluzone® Quadrivalent Influenza Virus Vaccine, No Preservative Fluzone® Quadrivalent Influenza Virus Vaccine, No Preservative

Comparison of Flu Vaccine Doses in Children

PHASE1

The purpose of this study is to evaluate the possibility that giving an inc...

Status

Completed

Location

Emory Children's Center - Pediatric Infectious Diseases

Start Date

2010-10

Trial ID

NCT01164553

Treatments Being Tested

Trivalent Inactivated Influenza Vaccine

High vs.Standard Dose Influenza Vaccine in Pediatric Solid Organ Transplant (SOT) Recipients

PHASE2

Influenza virus is a significant pathogen in pediatric solid organ transpla...

Status

Recruiting

Location

Stanford University

Start Date

2024-09-26

Trial ID

NCT05947071

Treatments Being Tested

Standard Dose Quadrivalent Inactivated Influenza Vaccine High Dose Quadrivalent Inactivated Influenza Vaccine

Immunogenicity and Safety of Fluzone® Quadrivalent, Southern Hemisphere 2015 Formulation (Intramuscular Route)

PHASE4

The aim of the study was to assess the immunogenicity and safety of Fluzone...

Status

Completed

Location

Sanofi Pasteur Investigational Site 002

Start Date

2015-06-17

Trial ID

NCT03546192

Treatments Being Tested

Fluzone Quadrivalent Influenza Vaccine

Study to Determine a Preference for Fluzone Vaccine Given Intradermally (ID) and Intramuscularly (IM) in Healthy Adults

PHASE2

To describe any degree of preference for the route of administration of Flu...

Status

Completed

Location

Multiple Locations

Start Date

2008-01

Trial ID

NCT00623181

Treatments Being Tested

Fluzone: Influenza virus vaccine Fluzone: Influenza virus vaccine

Safety, Reactogenicity, Immunogenicity, Efficacy of Influenza Vaccines Grippol® Quadri and Grippol® Plus in Volunteers

PHASE2

The aim of the study to assess the safety, reactogenicity, immunogenicity, ...

Status

Completed

Location

Federal State Budgetary Educational Institution of Higher Education "First St. Petersburg State Medical University named after academician I.P. Pavlova "of the Ministry of Health of the Russian Federation.

Start Date

2016-11

Trial ID

NCT03849560

Treatments Being Tested

Grippol® Quadri Grippol® Plus, trivalent (Yamagata lineage)Grippol® Plus, trivalent (Victoria lineage)

Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults

PHASE3

The purpose of the study is to evaluate the safety, tolerance and immunogen...

Status

Completed

Location

Multiple Locations

Start Date

2005-01

Trial ID

NCT01389479

Treatments Being Tested

Fluviral™Fluzone®

High vs. Standard Dose Influenza Vaccine in Lung Allograft Recipients

PHASE2

Lung allograft recipients have a higher burden of influenza disease and gre...

Status

Recruiting

Location

Vanderbilt University Medical Center

Start Date

2022-11-08

Trial ID

NCT05215327

Treatments Being Tested

High Dose Quadrivalent Inactivated Influenza Vaccine Standard Dose Quadrivalent Inactivated Influenza Vaccine

Previous Next